6[1]Ball DW,Bsylin SB ,De Butros AC. Medullary thyroid carcinoma[A]. In: Braverman LE ,Utiger RE,Eds. Wemer and Ingbar's, The Thyroid[M]. 8th ed. Philadelphia: Lippincott-Williams-Wilkins,2000.930-943.
7[2]Berndt I, Reuter M, Saller B,et al. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A[J]. J Clin Endocrinol Metab, 1998, 83(3):770-774.
8[4]Lombardo F,Baudin E,Chiefari E,et al. Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804[J]. J Clin Endocrinol Metab, 2002,87(4):1674-1680.
9[5]Heshmati HM, Gharib H, Khosla S, et al. Genetic testing in medullary thyroid carcinoma syndromes: mutation types and clinical significance[J].Mayo Clin Proc,1997,72(5):430-436.
10[6]Nunes AB, Ezabella MC, Pereira AC, et al. A novel Va1648Ile substitution in RET protooncogene observed in a Cys634Arg multiple endocrine neoplasia type 2A kindred presenting with an adrenocorticotropin-producing pheochromocytoma[J]. J Clin Endocrinol Metab, 2002 ,87(12):5658-5661.
